Latest Orphan drugs Stories
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Hematology (ASH) signal an important step forward in the development of treatment strategies for patients with hard-to-treat leukemia, myeloma, and myelofibrosis.
A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug called ponatinib in a phase I clinical trial.
A new study has found Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to die from their disease.
- An imitative word; an onomatopoetic word.